Fatal inhalational anthrax with unknown source of exposure in a 61-year-old woman in New York City
- PMID: 11851577
- DOI: 10.1001/jama.287.7.858
Fatal inhalational anthrax with unknown source of exposure in a 61-year-old woman in New York City
Abstract
A 61-year-old woman who was a New York City hospital employee developed fatal inhalational anthrax, but with an unknown source of anthrax exposure. The patient presented with shortness of breath, malaise, and cough that had developed 3 days prior to admission. Within hours of presentation, she developed respiratory failure and septic shock and required mechanical ventilation and vasopressor therapy. Spiral contrast-enhanced computed tomography of the chest demonstrated large bilateral pleural effusions and hemorrhagic mediastinitis. Blood cultures, as well as DNA amplification by polymerase chain reaction of the blood, bronchial washings, and pleural fluid specimens, were positive for Bacillus anthracis. The clinical course was complicated by liver failure, renal failure, severe metabolic acidosis, disseminated intravascular coagulopathy, and cardiac tamponade, and the patient died on the fourth hospital day. The cause of death was inhalational anthrax. Despite epidemiologic investigation, including environmental samples from the patient's residence and workplace, no mechanism for anthrax exposure has been identified.
Comment in
-
Bioterrorism preparedness and response: clinicians and public health agencies as essential partners.JAMA. 2002 Feb 20;287(7):898-900. doi: 10.1001/jama.287.7.898. JAMA. 2002. PMID: 11851584 No abstract available.
Similar articles
-
Fatal inhalational anthrax in a 94-year-old Connecticut woman.JAMA. 2002 Feb 20;287(7):863-8. doi: 10.1001/jama.287.7.863. JAMA. 2002. PMID: 11851578
-
Death due to bioterrorism-related inhalational anthrax: report of 2 patients.JAMA. 2001 Nov 28;286(20):2554-9. doi: 10.1001/jama.286.20.2554. JAMA. 2001. PMID: 11722269
-
Clinical presentation of inhalational anthrax following bioterrorism exposure: report of 2 surviving patients.JAMA. 2001 Nov 28;286(20):2549-53. doi: 10.1001/jama.286.20.2549. JAMA. 2001. PMID: 11722268
-
Inhalational anthrax and bioterrorism.Curr Opin Pulm Med. 2003 May;9(3):221-6. doi: 10.1097/00063198-200305000-00011. Curr Opin Pulm Med. 2003. PMID: 12682568 Review.
-
When bioterrorism strikes: diagnosis and management of inhalational anthrax.Semin Respir Infect. 2003 Sep;18(3):134-45. Semin Respir Infect. 2003. PMID: 14505276 Review.
Cited by
-
Soluble P-selectin rescues mice from anthrax lethal toxin-induced mortality through PSGL-1 pathway-mediated correction of hemostasis.Virulence. 2017 Oct 3;8(7):1216-1228. doi: 10.1080/21505594.2017.1282027. Epub 2017 Jan 19. Virulence. 2017. PMID: 28102766 Free PMC article.
-
Anthrax toxins induce shock in rats by depressed cardiac ventricular function.PLoS One. 2007 May 23;2(5):e466. doi: 10.1371/journal.pone.0000466. PLoS One. 2007. PMID: 17520025 Free PMC article.
-
Activated protein C ameliorates Bacillus anthracis lethal toxin-induced lethal pathogenesis in rats.J Biomed Sci. 2012 Nov 21;19(1):98. doi: 10.1186/1423-0127-19-98. J Biomed Sci. 2012. PMID: 23170801 Free PMC article.
-
Hemorrhagic pleural effusion secondary to sarcoidosis: A brief review.Ann Thorac Med. 2009 Jan;4(1):27-31. doi: 10.4103/1817-1737.44783. Ann Thorac Med. 2009. PMID: 19561920 Free PMC article.
-
Erythropoiesis suppression is associated with anthrax lethal toxin-mediated pathogenic progression.PLoS One. 2013 Aug 19;8(8):e71718. doi: 10.1371/journal.pone.0071718. eCollection 2013. PLoS One. 2013. PMID: 23977125 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical